What is the share price of RPG Life Sciences Limited (RPGLIFE) today?
The share price of RPGLIFE as on 17th April 2025 is ₹2201.80. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on RPG Life Sciences Limited (RPGLIFE) share?
The past returns of RPG Life Sciences Limited (RPGLIFE) share are- Past 1 week: 8.52%
- Past 1 month: 3.86%
- Past 3 months: 5.73%
- Past 6 months: -21.25%
- Past 1 year: 45.68%
- Past 3 years: 265.11%
- Past 5 years: 823.19%
What are the peers or stocks similar to RPG Life Sciences Limited (RPGLIFE)?
The peers or stocks similar to RPG Life Sciences Limited (RPGLIFE) include:What is the dividend yield % of RPG Life Sciences Limited (RPGLIFE) share?
The current dividend yield of RPG Life Sciences Limited (RPGLIFE) is 0.73.What is the market cap of RPG Life Sciences Limited (RPGLIFE) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of RPG Life Sciences Limited (RPGLIFE) is ₹3632.75 Cr as of 17th April 2025.What is the 52 week high and low of RPG Life Sciences Limited (RPGLIFE) share?
The 52-week high of RPG Life Sciences Limited (RPGLIFE) is ₹2974.95 and the 52-week low is ₹1381.What is the PE and PB ratio of RPG Life Sciences Limited (RPGLIFE) stock?
The P/E (price-to-earnings) ratio of RPG Life Sciences Limited (RPGLIFE) is 41.44. The P/B (price-to-book) ratio is 9.69.Which sector does RPG Life Sciences Limited (RPGLIFE) belong to?
RPG Life Sciences Limited (RPGLIFE) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy RPG Life Sciences Limited (RPGLIFE) shares?
You can directly buy RPG Life Sciences Limited (RPGLIFE) shares on Tickertape. Simply sign up, connect your demat account and place your order.
RPG Life Sciences Limited
RPGLIFE Share Price
2,201.800.77% (+16.80)
RPGLIFE Share Price Chart
High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
How to use scorecard? Learn more
RPGLIFE Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 45.91 | 9.69 | 0.73% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 49.39 | 6.29 | 0.54% |
RPGLIFE Analyst Ratings & Forecast
Detailed Forecast —
Forecast data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
RPGLIFE Company Profile
RPG Life Sciences Limited is engaged in manufacturing and marketing of pharmaceutical products. The Company operates across segments, including Domestic Formulations, International Formulations, Active Pharmaceutical Ingredients (API) and Biotech.
Investor Presentation
View olderRPGLIFE Similar Stocks (Peers)
Compare with peersSUNPHARMA
PE Ratio
43.78
1Y Return
15.50%
Buy Reco %
88.24
CIPLA
PE Ratio
29.62
1Y Return
12.46%
Buy Reco %
72.73
TORNTPHARM
PE Ratio
66.34
1Y Return
27.80%
Buy Reco %
68.00
MANKIND
PE Ratio
55.55
1Y Return
7.76%
Buy Reco %
81.25
DRREDDY
PE Ratio
17.34
1Y Return
2.34%
Buy Reco %
46.67
RPGLIFE Forecasts
Price
Revenue
Earnings
RPGLIFE Share Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRPGLIFE Company Revenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRPGLIFE Stock EPS (Earnings Per Share) Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRPGLIFE
Income
Balance Sheet
Cash Flow
Annual Normal View
RPGLIFE Income Statement
Annual Normal View
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 280.10 | 303.17 | 344.93 | 330.96 | 376.30 | 390.05 | 443.15 | 517.61 | 589.26 | 646.60 | ||||||||||
Raw Materials | 93.85 | 112.21 | 121.30 | 96.33 | 133.74 | 136.11 | 167.03 | 178.17 | 181.83 | 509.75 | ||||||||||
| Power & Fuel Cost | 11.23 | 9.10 | 10.44 | 10.38 | 11.54 | 11.27 | 12.69 | 13.65 | 14.36 | |||||||||||
| Employee Cost | 74.13 | 75.59 | 90.14 | 89.93 | 90.97 | 94.66 | 99.97 | 117.06 | 132.15 | |||||||||||
| Selling & Administrative Expenses | 38.80 | 55.41 | 63.13 | 59.43 | 56.84 | 58.40 | 67.07 | 73.63 | 80.47 | |||||||||||
| Operating & Other expenses | 37.83 | 12.45 | 20.50 | 39.66 | 27.64 | 17.77 | 6.15 | 26.77 | 44.10 | |||||||||||
EBITDA | 24.26 | 38.41 | 39.42 | 35.23 | 55.57 | 71.84 | 90.24 | 108.33 | 136.35 | 136.85 | ||||||||||
| Depreciation/Amortization | 10.15 | 11.31 | 14.34 | 15.32 | 16.36 | 16.47 | 15.66 | 15.50 | 17.07 | 20.55 | ||||||||||
| PBIT | 14.11 | 27.10 | 25.08 | 19.91 | 39.21 | 55.37 | 74.58 | 92.83 | 119.28 | 116.30 | ||||||||||
| Interest & Other Items | 2.49 | 3.64 | 4.72 | 4.86 | 2.76 | 1.79 | 1.41 | 1.15 | 1.44 | 0.58 | ||||||||||
| PBT | 11.62 | 23.46 | 20.36 | 15.05 | 36.45 | 53.58 | 73.17 | 91.68 | 117.84 | 115.72 | ||||||||||
| Taxes & Other Items | 0.00 | 2.45 | 6.91 | 4.24 | 7.44 | 13.58 | 21.69 | 24.04 | 30.18 | 36.59 | ||||||||||
| Net Income | 11.62 | 21.01 | 13.45 | 10.81 | 29.01 | 40.00 | 51.48 | 67.64 | 87.66 | 79.13 | ||||||||||
| EPS | 7.03 | 12.70 | 8.13 | 6.54 | 17.54 | 24.19 | 31.13 | 40.90 | 53.00 | 47.84 | ||||||||||
| DPS | 1.60 | 2.80 | 2.40 | 2.40 | 4.00 | 7.20 | 9.60 | 12.00 | 16.00 | 16.00 | ||||||||||
| Payout ratio | 0.23 | 0.22 | 0.30 | 0.37 | 0.23 | 0.30 | 0.31 | 0.29 | 0.30 | 0.33 |
RPGLIFE Company Updates
FY 2015
Annual report
PDFFY 2016
Annual report
PDFFY 2017
Annual report
PDFFY 2018
Annual report
PDFFY 2019
Annual report
PDFFY 2020
Annual report
PDFFY 2021
Annual report
PDFFY 2025
Investor Presentation
Jan 28PDF
Nov 8PDF
RPGLIFE Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| RPG Life Sciences Limited | 41.44 | 9.69 | 0.73% |
| Sun Pharmaceutical Industries Ltd | 43.78 | 6.25 | 0.77% |
| Cipla Ltd | 29.62 | 4.55 | 0.86% |
| Torrent Pharmaceuticals Ltd | 66.34 | 16.03 | 0.86% |
RPGLIFE Stock Price Comparison
Compare RPGLIFE with any stock or ETFCompare RPGLIFE with any stock or ETF
RPGLIFE
RPGLIFE Shareholdings
RPGLIFE Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
RPGLIFE Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
RPGLIFE Shareholding Pattern
RPGLIFE Shareholding History
Foreign Institutions
Mutual Funds Invested in RPGLIFE
A list of mutual funds holding the stock, ranked on the basis of Market-cap held which is calculated as the value of stock held in the portfolio divided by its market cap
Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding RPG Life Sciences Limited
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 1.1072% | Percentage of the fund’s portfolio invested in the stock 0.43% | Change in the portfolio weight of the stock over the last 3 months 0.05% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 61/72 (-5) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 1.0659% | Percentage of the fund’s portfolio invested in the stock 1.26% | Change in the portfolio weight of the stock over the last 3 months 0.07% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 21/98 (+9) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.9454% | Percentage of the fund’s portfolio invested in the stock 9.28% | Change in the portfolio weight of the stock over the last 3 months 1.40% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 9/28 (-7) |
Compare 3-month MF holding change on Screener
smallcases containing RPGLIFE stock
Looks like this stock is not in any smallcase yet.
RPGLIFE Events
RPGLIFE Dividend Trend
Increasing Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
RPGLIFE has increased dividends consistently over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 0.73%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹7.28 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
RPGLIFE Upcoming Dividends
No upcoming dividends are available
RPGLIFE Past Dividends
Cash Dividend
Ex DateEx DateJun 28, 2024
Final
Final | Div/Share: ₹16.00
Dividend/Share
₹16.00
Ex DateEx Date
Jun 28, 2024
Cash Dividend
Ex DateEx DateJul 21, 2023
Final
Final | Div/Share: ₹12.00
Dividend/Share
₹12.00
Ex DateEx Date
Jul 21, 2023
Cash Dividend
Ex DateEx DateJul 14, 2022
Final
Final | Div/Share: ₹9.60
Dividend/Share
₹9.60
Ex DateEx Date
Jul 14, 2022
Cash Dividend
Ex DateEx DateAug 13, 2021
Final
Final | Div/Share: ₹7.20
Dividend/Share
₹7.20
Ex DateEx Date
Aug 13, 2021
Cash Dividend
Ex DateEx DateMar 24, 2020
Interim
Interim | Div/Share: ₹4.00
Dividend/Share
₹4.00
Ex DateEx Date
Mar 24, 2020
RPGLIFE Stock News & Opinions
Articles & Videos
Spotlight
RPG Life Sciences soars as PAT jump 32% YoY to Rs 35 crore in Q3 FY25
Profit before tax (PBT) gained 31.93% to Rs 46.89 crore in Q3 FY25 from Rs 35.54 crore in Q3 FY24. Total expenses added 7.53% YoY to Rs 129.13 crore during the quarter. Employee benefits expense stood at Rs 28.71 crore (down 14.78% YoY), and finance costs came in at Rs 0.12 (down 14.28% YoY). On a nine-month basis, the company's consolidated net profit tumbled 11.46% to Rs 65.89 crore despite a 12.14% increase in revenue from operations to Rs 510.34 crore in 9M FY25 over 9M FY24. RPG Life Sciences in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). Powered by Capital Market - Live
2 months agoCapital Market - Live
Earnings
RPG Life Sciences standalone net profit rises 32.01% in the December 2024 quarter
Net profit of RPG Life Sciences rose 32.01% to Rs 34.93 crore in the quarter ended December 2024 as against Rs 26.46 crore during the previous quarter ended December 2023. Sales rose 12.37% to Rs 172.71 crore in the quarter ended December 2024 as against Rs 153.70 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales172.71153.70 12 OPM %28.4624.66 - PBDT52.3539.68 32 PBT46.8935.54 32 NP34.9326.46 32 Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
RPG Life Sciences schedules board meeting
RPG Life Sciences will hold a meeting of the Board of Directors of the Company on 24 January 2025.Powered by Capital Market - Live
3 months agoCapital Market - Live
Earnings
RPG Life Sciences standalone net profit declines 83.76% in the September 2024 quarter
Net profit of RPG Life Sciences declined 83.76% to Rs 4.20 crore in the quarter ended September 2024 as against Rs 25.86 crore during the previous quarter ended September 2023. Sales rose 12.13% to Rs 172.21 crore in the quarter ended September 2024 as against Rs 153.58 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales172.21153.58 12 OPM %26.6724.28 - PBDT47.7039.02 22 PBT42.3934.79 22 NP4.2025.86 -84 Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
RPG Life Sciences announces board meeting date
RPG Life Sciences will hold a meeting of the Board of Directors of the Company on 7 November 2024Powered by Capital Market - Live
5 months agoCapital Market - Live
RPG Life Sciences: Healthy Q1 Update, Management Speaks About Earnings And Growth Plans | ET Now
8 months agoET NOW
Harsh Goenka-backed RPG Life Sciences surges 15% on solid Q1FY25 results
8 months agoBusiness Standard
RPG Life Sciences: Healthy Q1 Update, Management Speaks About Earnings And Growth Plans | ET Now
8 months agoET NOW
RPG Life Sciences standalone net profit rises 21.09% in the June 2024 quarter
9 months agoBusiness Standard
Q2 Review: RPG Life Sciences MD On Q2 Report Card & More | BQ Prime
1 year agoBloomberg Quint
Over the last 5 years, revenue has grown at a yearly rate of 12.23%, vs industry avg of 9.04%
Over the last 5 years, market share stayed at 0.15%
Over the last 5 years, net income has grown at a yearly rate of 51.98%, vs industry avg of 15.28%